Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens

MLA

Francesca Ferretti, et al. “Characterization of Low Level Viraemia in HIV-Infected Patients Receiving Boosted Protease Inhibitor-Based Antiretroviral Regimens.” HIV Research & Clinical Practice, vol. 20, no. 4–5, Sept. 2019, pp. 107–10. EBSCOhost, https://doi.org/10.1080/25787489.2020.1716159.

APA

Francesca Ferretti, Nicola E. Mackie, Gurmit Kaur Jagjit Singh, Julie Fox, Steve Kaye, Myra O. McClure, Graham Taylor, & Marta Boffito. (2019). Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens. HIV Research & Clinical Practice, 20(4–5), 107–110. https://doi.org/10.1080/25787489.2020.1716159

Chicago

Francesca Ferretti, Nicola E. Mackie, Gurmit Kaur Jagjit Singh, Julie Fox, Steve Kaye, Myra O. McClure, Graham Taylor, and Marta Boffito. 2019. “Characterization of Low Level Viraemia in HIV-Infected Patients Receiving Boosted Protease Inhibitor-Based Antiretroviral Regimens.” HIV Research & Clinical Practice 20 (4–5): 107–10. doi:10.1080/25787489.2020.1716159.